This paper is in the following e-collection/theme issue:

Development of Instruments and Surveys (79) Participatory Research Protocols and Proposals (127)

Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/43091, first published .
Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model

Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model

Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model

Authors of this article:

Laurie Fraticelli1 Author Orcid Image ;   Julie Freyssenge2 Author Orcid Image ;   Emilie Promé-Combel3 Author Orcid Image ;   Eléonore Agnellet4 Author Orcid Image ;   Yesim Dargaud3 Author Orcid Image ;   Valérie Chamouard3, 4 Author Orcid Image
Article Authors Cited by (2) Tweetations (2) Metrics

Journals

  1. Chamouard V, Freyssenge J, Duport G, Volot F, Varin R, Giraud N, Dargaud Y, Fraticelli L. Evaluation of the care pathway in the context of the dispensing of emicizumab (Hemlibra) in community and hospital pharmacies in France: A patient satisfaction survey. Haemophilia 2023;29(6):1490 View
  2. Chamouard V, Freyssenge J, Clairaz-Mahiou B, Ferrera Bibas F, Fraticelli L. Evaluation of an e-Learning Program for Community Pharmacists for Dispensing Emicizumab (Hemlibra) in France: Nationwide Cross-Sectional Study. JMIR Formative Research 2024;8:e54656 View